![]() |
市场调查报告书
商品编码
1662768
2030 年实验室耗材市场预测:按产品类型、应用、最终用户和地区进行的全球分析Lab Consumables Market Forecasts to 2030 - Global Analysis By Product Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,全球实验室耗材市场预计在 2024 年将达到 135.2 亿美元,预计到 2030 年将达到 197.3 亿美元,预测期内的复合年增长率为 6.5%。实验室中用于各种目的(例如工业测试、诊断、研究等)的一次性用品和设备称为实验室耗材。这包括试管、过滤器、移液器、玻璃器皿、塑胶器皿、试剂和手套等安全设备。需要实验室消耗品来进行研究、分析样本并维护实验室的安全。这些消耗品设计用于一次性或短期使用,有助于维持实验室活动的准确性、效率和卫生。
根据世界卫生组织(WHO)的数据,慢性病是造成全球71%死亡的原因,其中2019年心血管疾病导致的死亡占所有死亡人数的31%。
诊断测试需求不断增加
测试过程中使用的各种耗材的需求是实验室耗材市场的主要驱动力,直接推动力是诊断测试需求的不断增长。随着人们越来越了解健康问题并寻求早期疾病诊断的诊断测试,试剂、检测套组、样本采集用品和实验室消耗品的使用越来越频繁。诊断检测的增加也是感染疾病爆发、慢性病发展和预防性医疗保健的结果。为了满足日益增长的检测需求,诊断中心、医院和实验室需要稳定的消耗品供应。
一次性产品对环境的影响
实验室耗材产业越来越关註一次性产品对环境的影响,因为微量吸管尖、试管和手套等一次性塑胶製品使用频繁,产生大量废弃物。这些消耗品在实验室中大量生产,并经常被丢弃在垃圾掩埋场,增加了塑胶污染并破坏了环境。生产和处理这些产品需要耗费大量的能源和资源,这进一步加剧了环境问题。为了减少实验室运作对环境的影响,同时保持测试的效率和安全性,人们越来越需要永续的替代品,例如可回收包装、可重复使用的实验室用具和生物分解性的材料。
增加研发投入
随着生物技术、製药、医学和环境科学等领域大力投资研发新药、诊断方法和新技术,对试剂、培养基、检测套组和塑胶器皿等优质实验室耗材的需求日益增加。这些消耗品对于各种实验室测试、分析和实验至关重要。此外,随着基因组学、个人化医疗和分子研究的兴起进一步刺激研发工作,实验室需要稳定供应专业、可靠的消耗品来支持尖端的研究发现,实验室消耗品市场将继续成长。
供应链中断
实验室耗材产业供应链中断可能会严重影响研究、诊断和医疗应用中使用的关键耗材的可用性和成本。对于试剂、玻璃器皿和移液器等消耗品,我们可能会因原料短缺、运输延误和物流困难等因素而出现库存短缺或前置作业时间延长的情况。此外,这些中断可能会增加生产商和最终用户的实验室消耗成本。此类中断也可能影响依赖快速准确检测的领域的医疗和科学进步的有效性,从而带来进一步的市场挑战。
COVID-19 的影响
COVID-19 疫情以多种方式影响了检测耗材市场。一方面,诊断检测特别是新冠病毒检测的增加,增加了对检测套组、试剂和个人防护设备等消耗品的需求。然而,物流挑战、原材料短缺和供应链延迟影响了关键测试耗材的及时供应。儘管存在这些障碍,但疫情刺激了诊断工具的创新,并凸显了有效消耗品在医疗保健和研究中的重要性,从而推动市场持续扩张。
临床诊断领域预计将成为预测期内最大的领域
由于对准确和及时的疾病诊断的需求不断增加,特别是慢性病和感染疾病的增加,预计临床诊断领域将在预测期内占据最大的市场份额,这反过来又增加了对试剂、检测套组和检体市场占有率材料等消耗品的需求。分子诊断和就地检验等诊断技术的进步进一步推动了实验室消耗品的消费,支持了临床诊断领域的扩张。
预计在预测期内,CRO(委外研发机构)部门的复合年增长率最高
由于外包临床测试和研究计划中使用的消耗品的需求不断增加,预计委外研发机构(CRO)部门将在预测期内见证最高成长率。由于製药、生物技术和医疗设备企业依赖 CRO 进行药物开发、安全测试和法规遵循,对试剂、检测套组、培养基和实验室用具的需求日益增加。临床测试和研发活动的成长进一步推动了 CRO 耗材市场的发展。
在预测期内,由于医疗保健基础设施的扩大、研发投入的增加以及诊断测试的需求不断增长,预计亚太地区将占据最大的市场占有率。中国、印度和日本等国家正在经历实验室活动的激增,尤其是在临床诊断和生物技术领域。这种增长导致对试剂、检测套组和实验室设备等消耗品的需求增加,从而促进了该地区医疗保健和研究格局的不断扩大。
预计北美地区在预测期内将呈现最高的复合年增长率。这是得益于强大的医疗保健系统、高额的研发投入以及不断增长的诊断测试需求。慢性病的增加以及分子诊断和生物技术的进步正在推动对试剂、检测套组和检测设备等消耗品的需求。此外,已建立的医疗设施和研究机构网路进一步加速了该地区实验室消耗品的消耗。
According to Stratistics MRC, the Global Lab Consumables Market is accounted for $13.52 billion in 2024 and is expected to reach $19.73 billion by 2030 growing at a CAGR of 6.5% during the forecast period. Disposable supplies and equipment used in labs for a range of purposes, such as industrial testing, diagnostics, and research, are referred to as lab consumables. These include of things like test tubes, filters, pipettes, glassware, plastic-ware, reagents, and gloves and other safety gear. In order to conduct research, analyze samples, and maintain safety in lab settings, lab consumables are necessary. They are made to be used only once or for a brief period of time, which helps to preserve accuracy, efficiency, and hygiene in laboratory activities.
According to the World Health Organization (WHO), chronic diseases cause 71% of all deaths worldwide, with cardiovascular diseases accounting for 31% of all fatalities in 2019.
Rising demand for diagnostic testing
The requirement for different consumables used in testing processes is directly fueled by the growing need for diagnostic testing, which is a major driver of the lab consumables market. Reagents, test kits, sample collection supplies, and laboratory consumables are used increasingly frequently as a result of people seeking diagnostic testing for early illness diagnosis as health issues become more well known. The rise in diagnostic testing is also a result of infectious disease outbreaks, the development of chronic illnesses, and the movement toward preventative healthcare. To accommodate the increasing demand for testing, diagnostic centers, hospitals, and laboratories need a steady supply of consumables.
Environmental impact of disposable products
Concern over the environmental effects of disposable products in the lab consumables sector is developing since single-use plastic items like pipette tips, test tubes, gloves, are used so frequently and generate a lot of waste. Large amounts of these consumables are produced in laboratories and frequently wind up in landfills, increasing plastic pollution and degrading the environment. Environmental problems are made worse by the significant energy and resource requirements for the manufacture and disposal of these goods. To lessen the environmental impact of lab operations while preserving testing efficiency and safety, there is a growing movement for sustainable alternatives, such as recyclable packaging, reusable lab equipment, and biodegradable materials.
Growing research and development (R&D) investments
High-quality lab consumables, such as reagents, culture medium, test kits, and plasticware, are becoming more and more necessary as sectors including biotechnology, pharmaceuticals, healthcare, and environmental science make significant investments in research and development to create new medications, diagnostic techniques, and technologies. For testing, analysis, and experimentation in a wide range of research applications, these consumables are essential. Furthermore, as genomics, personalized medicine, and molecular research increase, R&D efforts are further stimulated, leading to the market for lab consumables to continue growing as labs need a consistent supply of specialized and dependable supplies to support cutting-edge research discoveries.
Supply chain disruptions
The availability and cost of crucial supplies used in research, diagnostics, and healthcare applications can be greatly impacted by supply chain interruptions in the lab consumables industry. For consumables like reagents, glassware, and pipettes, factors like shortages of raw materials, delays in transit and logistical difficulties can result in stock-outs and prolonged lead times. Furthermore, these disruptions may increase the cost of lab consumables for both producers and end users. Such disruptions may also affect the effectiveness of health care and scientific advancement in sectors that depend on prompt, accurate testing, posing further market challenges.
Covid-19 Impact
The COVID-19 pandemic affected the market for lab consumables in a variety of ways. The rise in diagnostic testing, particularly for the detection of COVID-19, has, on the one hand, raised demand for consumables such as test kits, reagents, and personal protective equipment. However, the timely availability of crucial lab consumables was impacted by logistical difficulties, raw material shortages, and supply chain delays. The pandemic, in spite of these obstacles, spurred diagnostic tool innovation and brought attention to the significance of effective consumables in medical and research contexts, which resulted in sustained market expansion.
The clinical diagnostics segment is expected to be the largest during the forecast period
The clinical diagnostics segment is expected to account for the largest market share during the forecast period, due to rising demand for accurate, timely disease diagnosis, especially with the rise in chronic conditions and infectious diseases, fuels the need for consumables like reagents, test kits, and sample collection materials. Advances in diagnostic technologies, such as molecular diagnostics and point-of-care testing, further boost the consumption of lab consumables, supporting the expansion of the clinical diagnostics sector.
The contract research organizations (CROs) segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the contract research organizations (CROs) segment is predicted to witness the highest growth rate, due to rising demand for consumables used in clinical trials and research projects that are outsourced. Reagents, test kits, culture media, and laboratory equipment are becoming more and more necessary as pharmaceutical, biotechnology, and medical device businesses depend on CROs for drug development, safety testing, and regulatory compliance. The market for consumables in CROs is further enhanced by the growth of clinical trials and R&D activities.
During the forecast period, Asia Pacific region is expected to hold the largest market share, driven by expanding healthcare infrastructure, increasing investments in research and development, and rising demand for diagnostic testing. Countries like China, India, and Japan are witnessing a surge in laboratory activities, particularly in clinical diagnostics and biotechnology sectors. This growth enhances the need for consumables such as reagents, test kits, and laboratory equipment, contributing to the region's expanding healthcare and research landscape.
Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, owing to strong healthcare systems, high research and development investments, and growing diagnostic testing needs. The increasing prevalence of chronic diseases, along with advancements in molecular diagnostics and biotechnology, drives the demand for consumables like reagents, test kits, and lab equipment. Additionally, a well-established network of healthcare facilities and research institutions further accelerates the consumption of lab consumables in the region.
Key players in the market
Some of the key players profiled in the Lab Consumables Market include Thermo Fisher Scientific, Inc., Merck KGaA, Danaher Corporation, Agilent Technologies, Inc., Abbott Laboratories, Bio-Rad Laboratories, Inc., Corning Incorporated, Becton, Dickinson and Company (BD), Eppendorf AG, PerkinElmer, Inc., Sartorius AG, GE Healthcare Life Sciences, Lonza Group, Fisher Scientific, Waters Corporation, Labcon North America, Cell Signaling Technology, Inc., and SensoTech GmbH.
In January 2025, Merck, launched a beta version of M-Trust(TM), a secure cyber-physical trust platform, created to help solve the growing issues of product safety, traceability and counterfeiting.
In January 2025, Danaher Diagnostics LLC and Danaher Ventures LLC, two subsidiaries of Danaher Corporation announced that they have formed an investment partnership with Innovaccer Inc., a leading healthcare artificial intelligence (AI) company.